References
- Chong YY, Chew CN, Koh ET, Fock KM. A comparison of clinical and endoscopic features of bleeding and non-bleeding peptic ulcer in Singapore. Ann Acad Med Singapore 1996; 25: 496–9
- Chung IK, Kim EJ, Lee MS, Kim HS, Park SH, Lee MH, et al. Endoscopic factors predisposing to rebleeding following endoscopic hemostasis in bleeding peptic ulcers. Endoscopy 2001; 33: 969–75
- Higuchi K, Fujiwara Y, Tominaga K, Watanabe T, Shiba M, Nakamura S, et al. Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study. Aliment Pharmacol Ther 2003; 17: 111–17
- Arkkila PE, Seppala K, Kosunen TU, Haapiainen R, Kivilaakso E, Sipponen P, et al. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer. Am J Gastroenterol 2003; 98: 2149–56
- Arkkila PE, Seppala K, Kosunen TU, Sipponen P, Makinen J, Rautelin H, et al. Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers. Eur J Gastroenterol Hepatol 2005; 17: 93–101
- Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston. Am J Surg Pathol ;20 1994; 1996: 1161–81
- Kosunen TU, Seppala K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992; 339(8798)893–5
- Bermejo F, Boixeda D, Martin De Argila C, Lopez San Roman A, Defarges V, Hernandez Ranz H, et al. Healing of Helicobacter pylori gastric ulcers: only eradication matters. Rev Esp Enferm Dig 2003; 95: 625–8, 621–4
- Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 2001; 120: 594–606
- Kemppainen H, Raiha I, Kujari H, Sourander L. Characteristics of Helicobacter pylori-negative and -positive peptic ulcer disease. Age Ageing 1998; 27: 427–31
- Ma L, Chow JY, Cho CH. Effects of cigarette smoking on gastric ulcer formation and healing: possible mechanisms of action. J Clin Gastroenterol 1998; 27 Suppl 1: S80–6
- Konturek SJ, Bielanski W, Plonka M, Pawlik T, Pepera J, Konturek PC, et al. Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers. Scand J Gastroenterol 2003; 38: 923–30
- Tougas G, Chen Y, Hwang P, Liu MM, Eggleston A. Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. Domestic/International Gastroenterology Surveillance Study. Am J Gastroenterol 1999; 94: 2845–54
- Mitani K, Tatsuta M, Iishi H, Yano H, Uedo N, Iseki K, et al. Helicobacter pylori infection as a risk factor for gastric ulceration. Hepatogastroenterology 2004; 51: 309–12
- al-Assi MT, Genta RM, Karttunen TJ, Graham DY. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use. Endoscopy 1996; 28: 229–33
- Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175–86
- Sipponen P, Seppala K, Aarynen M, Helske T, Kettunen P. Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis. Gut 1989; 30: 922–9
- Labenz J. Consequences of Helicobacter pylori cure in ulcer patients. Baillieres Best Pract Res Clin Gastroenterol 2000; 14: 133–45